MRI and AST (MAST) Score for Non-Invasive Identification of Patients with Non-Alcoholic Steatohepatitis with Significant Fibrosis

Authors

Mazen Noureddin, Cedars Sinai Medical Center
Saleh Alqahtani, Johns Hopkins University
Bryan Gonzalez, Cedars-Sinai Medical Center
Jefrrey A. Gornbein, University of California, Los Angeles
Atel Al Attar, Cedars-Sinal Medical Center
Nabil Noureddin, University of Nevada, Las VegasFollow
Vivian Hwe, Cedars-Sinai Medical Center
Nader Binesh, Cedars-Sinai Medical Center
Rola Saouaf, Cedars-Sinai Medical Center
Anita Kohli, Arizona Liver Health
Maha Guindi, Cedars-Sinai Medical Center
Stephen A. Harrison, Pinnacle Clinical Research Center
Naim Alkhouri, UT Health San Antonio

Document Type

Abstract

Publication Date

11-1-2020

Publication Title

Hepatology

Volume

72

First page number:

928A

Last page number:

929A

Keywords

NAFLD; MRI plus AST; MRI-proton density fat fraction; MR elstography; NASH; Significant fibrosis

Disciplines

Gastroenterology | Hepatology | Medical Specialties | Medicine and Health Sciences

Language

English

Repository Citation

Noureddin, M., Alqahtani, S., Gonzalez, B., Gornbein, J. A., Al Attar, A., Noureddin, N., Hwe, V., Binesh, N., Saouaf, R., Kohli, A., Guindi, M., Harrison, S. A., Alkhouri, N. (2020). MRI and AST (MAST) Score for Non-Invasive Identification of Patients with Non-Alcoholic Steatohepatitis with Significant Fibrosis. Hepatology, 72 928A-929A.